Neuropathic pain in the cancer patient.
Cancer presents itself in numerous ways, adding to the complexity of any pain syndrome with which it is associated. Neuropathic pain, unlike many other pain syndromes, is difficult to treat even in the absence of cancer. The combination results in a heterogeneous group of patients with a complex set of symptoms. This makes the assessment of pain, classification of syndromes, and clinical study a challenge. If the disease is nonprogressive, general principles of care are essentially the same as in those without cancer. In patients with progressive disease and more refractory painful conditions, spinal anesthetic and neurosurgical therapies must often be considered. Under such circumstances, caregivers are forced to carefully balance uncertain benefits and risks, often without the luxury of time. More careful observation and controlled trials in these patients help facilitate this challenging process.
Clinical Research, Astra USA, Westborough, MA 01581, USA. robertallen@astra.us.astra.com
R R
RR
Allen
D003131:Combined Modality Therapy; D006801:Humans; D009369:Neoplasms / Q000503:physiopathology*; D009437:Neuralgia / Q000209:etiology* / Q000628:therapy; D009460:Neurologic Examination; D010147:Pain Measurement; D010166:Palliative Care